Category Archives: Drug Development

“Borne Out of Necessity and Data”: Conquering Mutations in Leukemia

Category: cancer, Drug Development, Targeted Therapy | Tagged , , , , , , , , , , , , , | 1 Comment

Industry’s Influence

Category: Drug Development, Housekeeping, Industry funding | Tagged , , , , , , , | Comments Off

How Much Money Do Drug Companies Pay the FDA?

Category: Drug Development, Housekeeping | Tagged , , , , | 1 Comment

Avastin for Ovarian Cancer

Category: cancer, Drug Development | Tagged , , , , | 3 Comments

Protons, Electrons, and Hepatitis C

Category: Drug Development, Hepatitis C | Tagged , , , , , , , , , , , , , , , , , , , , | 2 Comments

The false distinction between basic and applied science

Category: Drug Development | Tagged , , , , , , , , , | 3 Comments

Let the Death Panel Accusations Fly!

Category: Clinical Trials, Drug Development, ethics | Tagged , , , , , , , , , | Comments Off

What’s Next for Hepatitis C

Category: Drug Development, Hepatitis C | Tagged , , , , , , , , , , | 6 Comments

Helping People. Working System?

Category: cancer, Clinical Trials, Drug Development | Tagged , , , , , , , , | 2 Comments

Collaborative Clinical Trials: A Way Forward?

Category: Clinical Trials, Drug Development | Tagged , , , , , , , , , | Comments Off